25 results on '"Plöckinger, U"'
Search Results
2. The German National Action League for people with rare diseases: translating the three tiers center system into active co-operation, a one center experience
- Author
-
Plöckinger, U. and Ziagaki, A.
- Published
- 2019
- Full Text
- View/download PDF
3. 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
- Author
-
Plöckinger, U., Prasad, V., Ziagaki, A., Tiling, N., and Poellinger, A.
- Published
- 2018
- Full Text
- View/download PDF
4. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
- Author
-
O'Toole, D., Grossman, A., Gross, D., Fave, G. D., Barkmanova, J., O'Connor, J., Pape, U. F., Plöckinger, U., Åkerström, G., Annibale, B., Arnold, R., Bajetta, E., Chen, Y. J., Costa, F., Couvelard, A., Davar, J., Herder, W. D., Eriksson, B., Falconi, M., Ferone, D., Gustafsson, B., Hyrdel, R., Ivan, D., Kaltsas, G., Kianmanesh, R., Klöppel, G., Knigge, U. P., Komminoth, P., Kos Kudla, B., Kwekkeboom, D., Lebtahi, R., Lewington, V., Mcnicol, A. M., Mitry, E., Nilsson, O., Öberg, K., Papotti, M., Pavel, M., Perren, A., Platania, M., Rindi, G., Ruszniewski, P., Salazar, R., Scarpa, Aldo, Scheidhauer, K., Scoazec, J. Y., Sundin, A., Szpak, W., Taal, B., Vitek, P., Vullierme, M. P., and Wiedenmann, B.
- Subjects
Endocrinology, Diabetes and Metabolism ,Diagnostic accuracy ,insulinoma ,Neuroendocrine tumors ,Bioinformatics ,secretin ,0302 clinical medicine ,Endocrinology ,immune system diseases ,cancer diagnosis ,conference paper ,Biochemical markers ,biology ,Urinary 5-hydroxyindoleacetic acid ,Chromogranin A ,Fasting ,Hydroxyindoleacetic Acid ,Diabetes and Metabolism ,Neuroendocrine Tumors ,priority journal ,030220 oncology & carcinogenesis ,diagnostic accuracy ,5 hydroxyindoleacetic acid ,neuroendocrine tumor ,hormones, hormone substitutes, and hormone antagonists ,Neuroendocrine tumor test ,musculoskeletal diseases ,medicine.medical_specialty ,Standard of care ,MEDLINE ,610 Medicine & health ,030209 endocrinology & metabolism ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Patient information ,Internal medicine ,gastrin ,medicine ,Humans ,biochemistry ,human ,Insulinoma ,Gastrinoma ,gastrinoma ,Endocrine and Autonomic Systems ,business.industry ,practice guideline ,biochemical marker ,chromogranin A ,hypoglycemia ,patient information ,medicine.disease ,body regions ,biology.protein ,570 Life sciences ,Biomarkers ,business - Abstract
Biomarkers have been the mainstay in the diagnosis and follow-up of patients with neuroendocrine tumors (NETs) over the last few decades. In the beginning, secretory products from a variety of subtypes of NETs were regarded as biomarkers to follow during diagnosis and treatment: serotonin for small intestinal (SI) NETs, and gastrin and insulin for pancreatic NETs. However, it became evident that a large number of NETs were so-called nonfunctioning tumors without secreting substances that caused hormone-related symptoms. Therefore, it was necessary to develop so-called “general tumor markers.” The most important ones so far have been chromogranin A and neuron-specific enolase (NSE). Chromogranin A is the most important general biomarker for most NETs with a sensitivity and specificity somewhere between 60 and 90%. NSE has been a relevant biomarker for patients with high-grade tumors, particularly lung and gastrointestinal tract tumors. Serotonin and the breakdown product urinary 5-hydroxyindoleacetic acid (U-5-HIAA) is still an important marker for diagnosing and follow-up of SI NETs. Recently, 5-HIAA in plasma has been analyzed by high-performance liquid chromatography and fluorometric detection and has shown good agreement with U-5-HIAA analysis. In the future, we will see new tests including circulating tumor cells, circulating DNA and mRNA. Recently, a NET test has been developed analyzing gene transcripts in circulating blood. Preliminary data indicate high sensitivity and specificity for NETs. However, its precise role has to be validated in prospective randomized controlled trials which are ongoing right now.
- Published
- 2017
- Full Text
- View/download PDF
5. An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease
- Author
-
Kulessa, M., primary, Weyer‐Menkhoff, I., additional, Viergutz, L., additional, Kornblum, C., additional, Claeys, K. G., additional, Schneider, I., additional, Plöckinger, U., additional, Young, P., additional, Boentert, M., additional, Vielhaber, S., additional, Mawrin, C., additional, Bergmann, M., additional, Weis, J., additional, Ziagaki, A., additional, Stenzel, W., additional, Deschauer, M., additional, Nolte, D., additional, Hahn, A., additional, Schoser, B., additional, and Schänzer, A., additional
- Published
- 2019
- Full Text
- View/download PDF
6. Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart
- Author
-
Ziagaki, A, primary, Blaschke, D, additional, Haverkamp, W, additional, and Plöckinger, U, additional
- Published
- 2019
- Full Text
- View/download PDF
7. An integrative correlation of myopathology, phenotype and genotype in late onset Pompe disease.
- Author
-
Kulessa, M., Weyer‐Menkhoff, I., Viergutz, L., Kornblum, C., Claeys, K. G., Schneider, I., Plöckinger, U., Young, P., Boentert, M., Vielhaber, S., Mawrin, C., Bergmann, M., Weis, J., Ziagaki, A., Stenzel, W., Deschauer, M., Nolte, D., Hahn, A., Schoser, B., and Schänzer, A.
- Subjects
GLYCOGEN storage disease type II ,AUTOPHAGY ,SKELETAL muscle ,GENOTYPES ,MICROTUBULE-associated proteins - Abstract
Aims: Pompe disease is caused by pathogenic mutations in the alpha 1,4‐glucosidase (GAA) gene and in patients with late onset Pome disease (LOPD), genotype–phenotype correlations are unpredictable. Skeletal muscle pathology includes glycogen accumulation and altered autophagy of various degrees. A correlation of the muscle morphology with clinical features and the genetic background in GAA may contribute to the understanding of the phenotypic variability. Methods: Muscle biopsies taken before enzyme replacement therapy were analysed from 53 patients with LOPD. On resin sections, glycogen accumulation, fibrosis, autophagic vacuoles and the degree of muscle damage (morphology‐score) were analysed and the results were compared with clinical findings. Additional autophagy markers microtubule‐associated protein 1A/1B‐light chain 3, p62 and Bcl2‐associated athanogene 3 were analysed on cryosections from 22 LOPD biopsies. Results: The myopathology showed a high variability with, in most patients, a moderate glycogen accumulation and a low morphology‐score. High morphology‐scores were associated with increased fibrosis and autophagy highlighting the role of autophagy in severe stages of skeletal muscle damage. The morphology‐score did not correlate with the patient's age at biopsy, disease duration, nor with the residual GAA enzyme activity or creatine‐kinase levels. In 37 patients with LOPD, genetic analysis identified the most frequent mutation, c.‐32‐13T>G, in 95%, most commonly in combination with c.525delT (19%). No significant correlation was found between the different GAA genotypes and muscle morphology type. Conclusions: Muscle morphology in LOPD patients shows a high variability with, in most cases, moderate pathology. Increased pathology is associated with more fibrosis and autophagy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency
- Author
-
Johannsson, G., primary, Nespithal, K., additional, Plöckinger, U., additional, Alam, V., additional, and McLean, M., additional
- Published
- 2018
- Full Text
- View/download PDF
9. Neuroendokrine Tumoren des gastroenteropankreatischen Systems – eine heterogene Tumorentität mit variabler Prognose
- Author
-
Berndt, U, primary, Böhmig, M, additional, Pape, UF, additional, Tiling, N, additional, Plöckinger, U, additional, and Wiedenmann, B, additional
- Published
- 2015
- Full Text
- View/download PDF
10. Large Variations in Phenylalanine Concentrations Associate Adverse Cardiac Remodelling in Adult Patients With Phenylketonuria-A Long-Term CMR Study.
- Author
-
Tanacli R, Doeblin P, Faragli A, Hassel JH, Stehning C, Plöckinger U, Ziagaki A, and Kelle S
- Subjects
- Humans, Male, Female, Adult, Ventricular Remodeling physiology, Middle Aged, Magnetic Resonance Imaging methods, Phenylalanine blood, Phenylketonurias physiopathology, Phenylketonurias blood
- Abstract
Background: Despite a phenylalanine (Phe) restrictive diet, most adult patients with 'classical' phenylketonuria (PKU) maintain life-long Phe concentrations above the normal range and receive tyrosine (Tyr) and protein-enriched diets to maintain acceptable concentrations and ensure normal development. While these interventions are highly successful in preventing adverse neuropsychiatric complications, their long- term consequences are incompletely explored. We observed early cardiomyopathic characteristics and associated hemodynamic changes in adult PKU patients and present here the results of a longitudinal evaluation of cardiac phenotype., Methods: Fifteen adult patients with PKU (age: 39.8 ± 8.1 years, 9 males and 6 females) underwent a comprehensive follow-up cardiac magnetic resonance (CMR) imaging assessment after a mean follow-up interval of 8.3 ± 0.3 years from the initial baseline visit. The CMR protocol included left (LV) and right (RV) ventricular and left atrial (LA) volumetric assessment, LV parametric mapping (precontrast and postcontrast T1 and T2 maps, extracellular volume [ECV]), multilayer LV myocardial strain, systolic and diastolic hemodynamic forces and RV and LA strain and aortic distensibility evaluation. Plasma concentrations of Phe, tyrosine (Tyr) and other biochemical markers of disease were retrospectively collected. For comparison, a group of 20 matched control subjects undergoing an identical CMR protocol was included., Results: On average, the LV end-diastolic volume (EDV) (158 ± 29 vs. 143 ± 29 mL, p = 0.013) and end-systolic volume (ESV) (68 ± 18 vs. 62 ± 18 mL, p = 0.011) were lower at follow-up. In contrast, LV mass (LVM) (72 ± 25 vs. 82 ± 29 g, p < 0.001) and the ratio LVM/EDV (0.46 ± 0.12 vs. 0.58 ± 0.23 g/mL, p = 0.005) were increased, and T1 times were longer (940 ± 42 vs. 1010 ± 35 ms, p < 0.001). LV EF (57 ± 6 vs. 57 ± 7%, p = 0.90), longitudinal (GLS) and circumferential (GCS) systolic strain remained unchanged, but early diastolic hemodynamic (HD) forces were more markedly negative (-19.4 ± 7.0 vs. -26.5 ± 12.2%, p = 0.012), while LA strain 43.8 ± 11.3 vs. 37.3 ± 9.6%, p = 0.031) and aortic distensibility (6.38 ± 1.75 vs. 5.21 ± 1.17 10
-3 mmHg-1 , p = 0.008) decreased at follow-up. Compared with controls, PKU patients maintain reduced systolic function with lower LV EF and impaired GCS and have more markedly negative early diastolic HD pressures. A higher decrease in Phe concentration (ΔPhe) was associated with longer T1 times, ΔT1 (β = -0.78, p < 0.001), increased ECV, ΔECV (β = -0.61, p = 0.016) and a decrease in systolic function, ΔEF (β = 0.61, p = 0.017). In contrast, variations in Tyr concentrations did not affect the cardiac phenotype., Conclusions: At long-term follow-up, a marked drop in Phe plasma concentration was associated with detrimental cardiac remodelling consisting of decreased LV systolic function and increased diffuse fibrosis, in PKU patients. These new data prompt further investigation into the effects of large Phe variability over time and underline the usefulness of periodic cardiovascular assessment in adults with PKU., (© 2024 The Author(s). Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.)- Published
- 2025
- Full Text
- View/download PDF
11. Simultaneous assessment of vascular distensibility and vessel wall area at coronary, carotid, and aortic level in diabetic patients using CMR: detection of vascular remodeling.
- Author
-
Winkel DJ, Stoiber L, Xiong T, Stuber M, Hays AG, Plöckinger U, Doeblin P, Stehning C, and Kelle S
- Abstract
Aims: No data is available about the significance of cardiovascular magnetic resonance (CMR) derived vascular distensibility (VD) and vessel wall ratio (VWR) for risk stratification in patients with type 2 diabetes mellitus (T2DM). Therefore, this study aimed to investigate the effects of T2DM on VD and VWR using CMR in both central and peripheral territories., Methods: Thirty-one T2DM-patients and nine controls underwent CMR. Angulation of the aorta, the common carotid, and the coronary arteries was performed to obtain cross-sectional vessel areas., Results: In T2DM the Carotid-VWR and the Aortic-VWR correlated significantly. Mean values of Carotid-VWR and Aortic-VWR were significantly higher in T2DM than in controls. Coronary-VD was significantly lower in T2DM than in controls. No significant difference in Carotid-VD or Aortic-VD in T2DM vs. controls, respectively, could be observed. In a subgroup of thirteen T2DM patients with coronary artery disease (CAD), Coronary-VD was significantly lower and Aortic-VWR was significantly higher compared to T2DM patients without CAD., Conclusion: CMR allows a simultaneous evaluation of the structure and function of three important vascular territories to detect vascular remodeling in T2DM., Competing Interests: SK received support from the DZHK (German Center for Cardiovascular Research), Partner Site Berlin. SK was supported by Philips Healthcare. This work was partially funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB-1470 - B06. CS is an employee of Philips Healthcare. PD owns stock of Bayer and Siemens., (AJCD Copyright © 2023.)
- Published
- 2023
12. Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring's outcome in phenylketonuria.
- Author
-
Grohmann-Held K, Burgard P, Baerwald CGO, Beblo S, Vom Dahl S, Das A, Dokoupil K, Fleissner S, Freisinger P, Heddrich-Ellerbrok M, Jung A, Korpel V, Krämer J, Lier D, Maier EM, Meyer U, Mühlhausen C, Newger M, Och U, Plöckinger U, Rosenbaum-Fabian S, Rutsch F, Santer R, Schick P, Schwarz M, Spiekerkötter U, Strittmatter U, Thiele AG, Ziagaki A, Mütze U, Gleich F, Garbade SF, and Kölker S
- Subjects
- Pregnancy, Child, Female, Humans, Retrospective Studies, Phenylalanine, Diet, Child Behavior, Syndrome, Pregnancy Outcome, Phenylketonuria, Maternal therapy, Phenylketonurias
- Abstract
To prevent maternal phenylketonuria (PKU) syndrome low phenylalanine concentrations (target range, 120-360 μmol/L) during pregnancy are recommended for women with PKU. We evaluated the feasibility and effectiveness of current recommendations and identified factors influencing maternal metabolic control and children's outcome. Retrospective study of first successfully completed pregnancies of 85 women with PKU from 12 German centers using historical data and interviews with the women. Children's outcome was evaluated by standardized IQ tests and parental rating of child behavior. Seventy-four percent (63/85) of women started treatment before conception, 64% (54/85) reached the phenylalanine target range before conception. Pregnancy planning resulted in earlier achievement of the phenylalanine target (18 weeks before conception planned vs. 11 weeks of gestation unplanned, p < 0.001) and lower plasma phenylalanine concentrations during pregnancy, particularly in the first trimester (0-7 weeks of gestation: 247 μmol/L planned vs. 467 μmol/L unplanned, p < 0.0001; 8-12 weeks of gestation: 235 μmol/L planned vs. 414 μmol/L unplanned, p < 0.001). Preconceptual dietary training increased the success rate of achieving the phenylalanine target before conception compared to women without training (19 weeks before conception vs. 9 weeks of gestation, p < 0.001). The majority (93%) of children had normal IQ (mean 103, median age 7.3 years); however, IQ decreased with increasing phenylalanine concentration during pregnancy. Good metabolic control during pregnancy is the prerequisite to prevent maternal PKU syndrome in the offspring. This can be achieved by timely provision of detailed information, preconceptual dietary training, and careful planning of pregnancy., (© 2022 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.)
- Published
- 2022
- Full Text
- View/download PDF
13. Cardiac Magnetic Resonance Reveals Incipient Cardiomyopathy Traits in Adult Patients With Phenylketonuria.
- Author
-
Tanacli R, Hassel JH, Gebker R, Berger A, Gräfe M, Schneeweis C, Doeblin P, Fleck E, Stehning C, Tacke F, Pieske B, Spranger J, Plöckinger U, Ziagaki A, and Kelle S
- Subjects
- Adult, Humans, Magnetic Resonance Spectroscopy, Phenotype, Phenylalanine blood, Tyrosine blood, Young Adult, Cardiomyopathies diagnostic imaging, Phenylketonurias complications
- Abstract
Background Phenylketonuria is the most common inborn error of amino acid metabolism, where oxidative stress and collateral metabolic abnormalities are likely to cause cardiac structural and functional modifications. We aim herein to characterize the cardiac phenotype of adult subjects with phenylketonuria using advanced cardiac imaging. Methods and Results Thirty-nine adult patients with phenylketonuria (age, 30.5±8.7 years; 10-year mean phenylalanine concentration, 924±330 µmol/L) and 39 age- and sex-matched healthy controls were investigated. Participants underwent a comprehensive cardiac magnetic resonance and echocardiography examination. Ten-year mean plasma levels of phenylalanine and tyrosine were used to quantify disease activity and adherence to treatment. Patients with phenylketonuria had thinner left ventricular walls (septal end-diastolic thickness, 7.0±17 versus 8.8±1.7 mm [ P <0.001]; lateral thickness, 6.1±1.4 versus 6.8±1.2 mm [ P =0.004]), more dilated left ventricular cavity (end-diastolic volume, 87±14 versus 80±14 mL/m
2 [ P =0.0178]; end-systolic volume, 36±9 versus 29±8 mL/m2 [ P <0.001]), lower ejection fraction (59±6% versus 64±6% [ P <0.001]), reduced systolic deformation (global circumferential strain, -29.9±4.2 % versus -32.2±5.0 % [ P =0.027]), and lower left ventricular mass (38.2±7.9 versus 47.8±11.0 g/m2 [ P <0.001]). T1 native values were decreased (936±53 versus 996±26 ms [ P <0.001]), with particular low values in patients with phenylalanine >1200 µmol/L (909±48 ms). Both mean phenylalanine ( P =0.013) and tyrosine ( P =0.035) levels were independently correlated with T1; and in a multiple regression model, higher phenylalanine levels and higher left ventricular mass associate with lower T1. Conclusions Cardiac phenotype of adult patients with phenylketonuria reveals some traits of an early-stage cardiomyopathy. Regular cardiology follow-up, tighter therapeutic control, and prophylaxis of cardiovascular risk factors, in particular dyslipidemia, are recommended.- Published
- 2021
- Full Text
- View/download PDF
14. Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry.
- Author
-
Begum N, Maasberg S, Pascher A, Plöckinger U, Gress TM, Wurst C, Weber F, Raffel A, Krausch M, Holzer K, Bartsch DK, Musholt TJ, Keck T, Anlauf M, Rinke A, Pape UF, and Goretzki PE
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Gastrointestinal Neoplasms mortality, Gastrointestinal Neoplasms pathology, Germany, Humans, Male, Margins of Excision, Middle Aged, Neoplasm Staging, Neuroendocrine Tumors mortality, Neuroendocrine Tumors pathology, Pancreatic Neoplasms mortality, Pancreatic Neoplasms pathology, Registries, Retrospective Studies, Survival Rate, Treatment Outcome, Young Adult, Gastrointestinal Neoplasms surgery, Neuroendocrine Tumors surgery, Pancreatic Neoplasms surgery
- Abstract
Background: Neuroendocrine neoplasia (NEN) are rare and heterogenous tumours. Few data exist on the impact of surgical therapy., Materials and Methods: This is a retrospective analysis of prospectively collected data of gastroenteropancreatic NEN in the German NET-Registry (1999-2012). It focuses on patients without distant metastases (limited disease, LD, stage I-IIIB)., Results: Data of 2239 patients with NEN were recorded. Median age was 59 years, the gender ratio was 1:1.3 (f:m). A total of 986 patients (44%) had LD, and the 5-year survival rate (5 years) was 77% for all and 90% for patients with LD. A total of 1635 patients (73%) received a surgical therapy (1st to 6th line); the 5 and 10 ysr were 83/65% after and 59/35% without surgery for all patients (p < .001). The resection margins in the LD patients were 76%, 16%, and 3% for R0, R1 and R2, respectively. The 10 ysr was 84%, 59% and 42% for R0, R1 and R2 resections, respectively (p = .021 R0/R1, p < .001 R0/R2). The R0 resection rate was 75% for G1/G2 NET and 67% for G3 NEC., Conclusion: The rate of complete tumour resection (R0) in LD is independent of tumour grading, and R0 resection is the key determinant of long-term survival, as demonstrated by the 10 ysr. of 84%. All NEN patients with limited disease should be considered for operation, if possible, as the best 10-year survival is shown after an R0 resection.
- Published
- 2020
- Full Text
- View/download PDF
15. Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study.
- Author
-
Klimek A, Baerwald C, Schwarz M, Rutsch F, Parhofer KG, Plöckinger U, Heddrich-Ellerbrok M, Vom Dahl S, Schöne K, Ott M, Lang F, and Hennermann JB
- Subjects
- Activities of Daily Living psychology, Adolescent, Adult, Amino Acids administration & dosage, Cross-Sectional Studies, Depression epidemiology, Depression etiology, Diet, Protein-Restricted psychology, Dietary Supplements statistics & numerical data, Female, Health Status, Humans, Male, Middle Aged, Patient Compliance psychology, Patient Compliance statistics & numerical data, Phenylalanine blood, Phenylketonurias blood, Phenylketonurias diet therapy, Prevalence, Surveys and Questionnaires, Young Adult, Diet, Protein-Restricted statistics & numerical data, Feeding Behavior psychology, Phenylketonurias psychology, Quality of Life
- Abstract
Background: Only few data on dietary management of adult phenylketonuria (PKU) patients are published., Objectives: This study aimed to assess living situation, dietary practices, and health conditions of early-treated adult PKU patients., Methods: A total of 183 early-treated PKU patients ≥18 years from 8 German metabolic centers received access to an online survey, containing 91 questions on sociodemographic data, dietary habits, and health conditions., Results: 144/183 patients (66% females) completed the questionnaire. Compared with German population, the proportion of single-person households was higher (22 vs. 47%), the rate of childbirth was lower (1.34 vs. 0.4%), but educational and professional status did not differ. 82% of the patients adhered to a low-protein diet, 45% consumed modified low-protein food almost daily, and 84% took amino acid mixtures regularly. 48% of the patients never interrupted diet, and 14% stopped diet permanently. 69% of the patients reported to feel better with diet, and 91% considered their quality of life at least as good. The prevalence of depressive symptoms was high (29%) and correlated significantly to phenylalanine blood concentrations (p = 0.046). However, depressive symptoms were only mild in the majority of patients., Conclusion: This group of early-treated adult German PKU patients is socially well integrated, reveals a surprisingly high adherence to diet and amino acid intake, and considers the restrictions of diet to their daily life as low., (© 2020 S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
16. The cardiovascular phenotype of adult patients with phenylketonuria.
- Author
-
Azabdaftari A, van der Giet M, Schuchardt M, Hennermann JB, Plöckinger U, and Querfeld U
- Subjects
- Adolescent, Adult, Body Mass Index, C-Reactive Protein metabolism, Cardiovascular Diseases blood, Cardiovascular Diseases pathology, Dietary Proteins blood, Female, Humans, Male, Middle Aged, Oxidative Stress physiology, Phenylketonurias blood, Phenylketonurias pathology, Risk Factors, Vascular Stiffness physiology, Young Adult, Cardiovascular Diseases metabolism, Phenylketonurias metabolism
- Abstract
Background: Patients with Phenylketonuria (PKU) are exposed to multiple cardiovascular risk factors, but the clinical significance of these abnormalities is yet unknown. The purpose of this study was to characterize the cardiovascular phenotype in adult patients with PKU by clinical and dietary data, measurements of biochemical markers, and non-invasive examination of vascular functions., Results: Twenty-three adult patients with PKU (age: 18-47 y; 30.8 ± 8.4 y) and 28 healthy controls (age: 18-47 y; 30.1 ± 9.1 y) were included in this study. PKU patients had significantly higher systolic and diastolic blood pressure, increased resting heart rate and a higher body mass index. Total cholesterol and non-HDL cholesterol levels were significantly increased in PKU patients, whereas plasma levels of HDL cholesterol and its subfraction HDL2 (but not HDL3) were significantly decreased. The inflammatory markers C-reactive protein and serum amyloid A protein and the serum oxidative stress marker malondialdehyde were significantly higher in patients with PKU. Venous occlusion plethysmography showed marked reduction in post-ischemic blood flow and the carotid to femoral pulse wave velocity was significantly increased demonstrating endothelial dysfunction and increased vascular stiffness., Conclusions: This study shows that the cardiovascular phenotype of adult PKU patients is characterized by an accumulation of traditional cardiovascular risk factors, high levels of inflammatory and oxidative stress markers, endothelial dysfunction and vascular stiffness. These data indicate the need for early cardiovascular risk reduction in patients with PKU.
- Published
- 2019
- Full Text
- View/download PDF
17. GnRH antagonist treatment of malignant adrenocortical tumors.
- Author
-
Doroszko M, Chrusciel M, Stelmaszewska J, Slezak T, Anisimowicz S, Plöckinger U, Quinkler M, Bonomi M, Wolczynski S, Huhtaniemi I, Toppari J, and Rahman NA
- Subjects
- Adrenal Cortex Neoplasms genetics, Adrenal Cortex Neoplasms metabolism, Adrenal Cortex Neoplasms pathology, Adult, Aged, Animals, Cell Line, Tumor, Cell Proliferation drug effects, Cell Survival drug effects, Female, Gene Expression Regulation, Neoplastic, Gonadotropin-Releasing Hormone pharmacology, Gonadotropin-Releasing Hormone therapeutic use, Hormone Antagonists pharmacology, Humans, Male, Mice, Transgenic, Middle Aged, Receptors, FSH genetics, Receptors, FSH metabolism, Receptors, LH genetics, Receptors, LH metabolism, Receptors, LHRH genetics, Receptors, LHRH metabolism, Adrenal Cortex Neoplasms drug therapy, Gonadotropin-Releasing Hormone analogs & derivatives, Gonadotropin-Releasing Hormone antagonists & inhibitors, Hormone Antagonists therapeutic use
- Abstract
Aberrantly expressed G protein-coupled receptors in tumors are considered as potential therapeutic targets. We analyzed the expressions of receptors of gonadotropin-releasing hormone (GNRHR), luteinizing hormone/chorionic gonadotropin (LHCGR) and follicle-stimulating hormone (FSHR) in human adrenocortical carcinomas and assessed their response to GnRH antagonist therapy. We further studied the effects of the GnRH antagonist cetrorelix acetate (CTX) on cultured adrenocortical tumor (ACT) cells (mouse Cα1 and Y-1, and human H295R), and in vivo in transgenic mice (SV40 T-antigen expression under inhibin α promoter) bearing Lhcgr and Gnrhr in ACT. Both models were treated with control (CT), CTX, human chorionic gonadotropin (hCG) or CTX+hCG, and their growth and transcriptional changes were analyzed. In situ hybridization and qPCR analysis of human adrenocortical carcinomas (n = 11-13) showed expression of GNRHR in 54/73%, LHCGR in 77/100% and FSHR in 0%, respectively. CTX treatment in vitro decreased cell viability and proliferation, and increased caspase 3/7 activity in all treated cells. In vivo, CTX and CTX+hCG (but not hCG alone) decreased ACT weights and serum LH and progesterone concentrations. CTX treatment downregulated the tumor markers Lhcgr and Gata4. Upregulated genes included Grb10, Rerg, Nfatc and Gnas, all recently found to be abundantly expressed in healthy adrenal vs ACT. Our data suggest that CTX treatment may improve the therapy of human adrenocortical carcinomas by direct action on GNRHR-positive cancer cells inducing apoptosis and/or reducing gonadotropin release, directing tumor cells towards a healthy adrenal gene expression profile.
- Published
- 2019
- Full Text
- View/download PDF
18. Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing Factors.
- Author
-
Zimmermann A, Zwerenz R, Droste M, Schöfl C, Strasburger CJ, Plöckinger U, Ziagaki A, Honegger J, Dixius A, Millaku B, Toenges G, Beutel ME, and Weber MM
- Abstract
Objective: Acromegalic patients display a distinct neuropsychological profile and suffer from chronic physical complaints. We aimed to investigate in more detail these aspects in acromegalic patients, dependent on influencing factors like disease activity, age, sex, chronic medication, surgery, pituitary radiation, pituitary insufficiency and comorbidities. Design: Cross sectional, multicentric. Methods: 129 patients (M/W 65/64, 58.3 ± 12.7 years, 53/76 with active/controlled disease). Acromegalic patients completed the following inventories: NEO-FFI, IIP-D, and the Giessen Complaints List (GBB-24), after written informed consent. Age, sex, IGF-1 concentrations, comorbidities, treatment modalities and pituitary insufficiency were documented. Results: Acromegalic patients or specific patient-subgroups were more agreeable, neurotic, exploitable/permissive, introverted/socially avoidant, non-assertive/insecure, nurturant and less open to experience, cold/denying, domineering, compared to normal values from the healthy population (controls). Multivariable analysis demonstrated that these overall results were due to the specific patient subgroups as patients on chronic medication, with arthrosis and pituitary insufficiency. Disease activity was only associated with the trait nurturant. Higher scores for introversion were associated with arthrosis. Lower domineering was independent of any disease- or treatment related variable or comorbidity. The GBB inventory showed overall higher scores in patients, with higher scores for exhaustion and general complaints being associated with pituitary insufficiency, coronary heart disease and history of malignancy in the multivariable analysis. Joint complaints were independent of any disease- or treatment- related variable. Conclusions: We define new aspects of a distinct neuropsychological profile in patients with acromegaly, which are largely independent of disease activity. Chronic physical complaints are more pronounced in patients than in controls, with exhaustion and general complaints showing no association with disease activity.
- Published
- 2018
- Full Text
- View/download PDF
19. Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome.
- Author
-
Plöckinger U, Chrusciel M, Doroszko M, Saeger W, Blankenstein O, Weizsäcker K, Kroiss M, Hauptmann K, Radke C, Pöllinger A, Tiling N, Steinmüller T, Huhtaniemi I, Quinkler M, Bertherat J, Lacroix A, and Rahman N
- Abstract
Context: Elevated human choriogonadotropin (hCG) may stimulate aberrantly expressed luteinizing hormone (LH)/hCG receptor (LHCGR) in adrenal glands, resulting in pregnancy-induced bilateral macronodular adrenal hyperplasia and transient Cushing syndrome (CS)., Objective: To determine the role of LHCGR in transient, pregnancy-induced CS., Design Setting Patient and Intervention: We investigated the functional implications of LHCGRs in a patient presenting, at a tertiary referral center, with repeated pregnancy-induced CS with bilateral adrenal hyperplasia, resolving after parturition., Main Outcome Measures and Results: Acute testing for aberrant hormone receptors was negative except for arginine vasopressin (AVP)-increased cortisol secretion. Long-term hCG stimulation induced hypercortisolism, which was unsuppressed by dexamethasone. Postadrenalectomy histopathology demonstrated steroidogenically active adrenocortical hyperplasia and ectopic cortical cell clusters in the medulla. Quantitative polymerase chain reaction showed upregulated expression of LHCGR , transcription factors GATA4 , ZFPM2 , and proopiomelanocortin ( POMC ), AVP receptors (AVPRs) AVPR1A and AVPR2 , and downregulated melanocortin 2 receptor ( MC2R ) vs control adrenals. LHCGR was localized in subcapsular, zona glomerulosa, and hyperplastic cells. Single adrenocorticotropic hormone-positive medullary cells were demonstrated in the zona reticularis. The role of adrenal adrenocorticotropic hormone was considered negligible due to downregulated MC2R . Coexpression of CYP11B1/CYP11B2 and AVPR1A/AVPR2 was observed in ectopic cortical cells in the medulla. hCG stimulation of the patient's adrenal cell cultures significantly increased cyclic adenosine monophosphate, corticosterone, 11-deoxycortisol, cortisol, and androstenedione production. CTNNB1 , PRKAR1A , ARMC5 , and PRKACA gene mutational analyses were negative., Conclusion: Nongenetic, transient, somatic mutation-independent, pregnancy-induced CS was due to hCG-stimulated transformation of LHCGR-positive undifferentiated subcapsular cells (presumably adrenocortical progenitors) into LHCGR-positive hyperplastic cortical cells. These cells respond to hCG stimulation with cortisol secretion. Without the ligand, they persist with aberrant LHCGR expression and the ability to respond to the same stimulus.
- Published
- 2017
- Full Text
- View/download PDF
20. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease.
- Author
-
Prasad V, Tiling N, Denecke T, Brenner W, and Plöckinger U
- Subjects
- Adult, Diagnosis, Differential, Feasibility Studies, Female, Humans, Male, Middle Aged, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Mass Screening methods, Neuroendocrine Tumors diagnostic imaging, Organometallic Compounds, Pancreatic Neoplasms diagnostic imaging, Positron Emission Tomography Computed Tomography methods, von Hippel-Lindau Disease diagnostic imaging
- Abstract
Purpose: Neuroendocrine tumours of the pancreas (pNET) are observed in 8 - 17 % of patients with von Hippel-Lindau disease (vHLD), and 11 - 20 % of these patients develop metastatic disease. MRI and CT have a very high resolution; however, their sensitivity and specificity for the detection of pNET amongst cystic lesions in the pancreas of vHLD patients are generally considered insufficient. In contrast, (68)Ga-DOTATOC PET/CT demonstrates a high sensitivity for the diagnosis and staging of neuroendocrine tumours. In this study we investigated the potential role of (68)Ga-DOTATOC PET/CT in screening of patients with vHLD., Method: (68)Ga-DOTATOC PET/three-phase contrast-enhanced CT was performed according to guidelines in all consecutive vHLD patients between January 2012 and November 2015. All patients underwent additional MRI imaging of the abdomen, spine, and head. Chromogranin A (CgA) was determined at the time of the PET/CT examination. A lesion seen on (68)Ga-DOTATOC PET in the pancreas was defined as positive if the uptake was visually higher than in the surrounding tissues. Lesions were quantified using maximum SUV., Results: Overall, 20 patients (8 men, 12 women; mean age 44.7 ± 11.1 years) were prospectively examined. Genetically, 12 patients had type 1 vHLD and 8 had type 2 vHLD. (68)Ga-DOTATOC PET/CT detected more pNET than morphological imaging (CT or MRI): 11 patients (55 %; 8 type 1, 3 type 2) vs. 9 patients (45 %; 6 type 1, 3 type 2). The concentration of CgA was mildly elevated in 2 of 11 patients with pNET. The mean SUVmax of the pancreatic lesions was 18.9 ± 21.9 (range 5.0 - 65.6). Four patients (36.4 %) had multiple pNETs. The mean size of the lesions on CT and/or MRI was 10.4 ± 8.3 mm (range 4 - 38 mm), and 41.1 % were larger than 10 mm. In addition, somatostatin receptor-positive cerebellar and spinal haemangioblastomas were detected in three patients (SUVmax 2.1 - 10.1). One patient presented with a solitary somatostatin receptor-positive lymph node metastasis. pNETs were observed more frequently in vHLD type 1 than type 2 (66.7 % vs. 37.5 %, p = 0.089). None of the patients showed progressive disease during follow-up., Conclusion: In this study, (68)Ga-DOTATOC PET detected pNETs in a higher proportion of patients with vHLD than found in previous studies with (111)In-octreoscan, the imaging method recommended by the NCCN. We therefore suggest (68)Ga-DOTATOC PET/CT as the more sensible screening tool.
- Published
- 2016
- Full Text
- View/download PDF
21. Pregnancy in patients with mucopolysaccharidosis: a case series.
- Author
-
Stewart FJ, Bentley A, Burton BK, Guffon N, Hale SL, Harmatz PR, Kircher SG, Kochhar PK, Mitchell JJ, Plöckinger U, Graham S, Sande S, Sisic Z, and Johnston TA
- Abstract
The mucopolysaccharidoses (MPS disorders) are rare inherited diseases associated with multi-organ accumulation of glycosaminoglycans, leading to musculoskeletal, respiratory, cardiac, neurological, ophthalmological, otolaryngological, and gastrointestinal abnormalities. As a result of improvements in diagnosis, multi-disciplinary care, and therapies such as enzyme replacement therapy and hematopoietic stem cell transplantation, an increasing number of patients with MPS are reaching adulthood and are involved in family planning. Data on fertility and pregnancy outcome in MPS is sparse and comprises primarily isolated case reports. To address this evidence gap, we present a case series on fertility and pregnancy in eight mothers and five fathers with MPS. This case series demonstrates that women with MPS have high-risk pregnancies and deliveries secondary to their underlying disease. However, with appropriate pre-conceptual multi-disciplinary evaluation, optimization and discussion regarding potential risks, combined with regular multi-disciplinary maternal and fetal surveillance in a tertiary center, the outcome of most pregnancies in this case series seems to be favorable with all babies developing normally. Partners of fathers with MPS had uncomplicated pregnancies and deliveries. All children were healthy, with normal growth and development.
- Published
- 2016
- Full Text
- View/download PDF
22. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
- Author
-
Prasad V, Sainz-Esteban A, Arsenic R, Plöckinger U, Denecke T, Pape UF, Pascher A, Kühnen P, Pavel M, and Blankenstein O
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Gene Expression Regulation, Humans, Hyperinsulinism complications, Hyperinsulinism metabolism, Hypoglycemia complications, Male, Middle Aged, Pancreas metabolism, Retrospective Studies, Young Adult, Gallium Radioisotopes, Hyperinsulinism diagnostic imaging, Positron Emission Tomography Computed Tomography, Receptors, Somatostatin metabolism
- Abstract
Purpose: To explore the role of (68)Ga-DOTATATE/DOTATOC PET/CT (SR PET/CT) in patients with suspicion of or histopathologically proven pancreatogenic hyperinsulinaemic hypoglycaemia., Methods: We included 13 patients with histopathologically proven or a high clinical suspicion of pancreatogenic hyperinsulinaemia. All the patients underwent a SR PET/CT scan. The results were correlated with histopathological findings. Normalization of blood glucose levels after resection of the pancreatic lesion, as well as a cytological and/or pathological diagnosis of insulinoma, was considered the diagnostic gold standard for insulinoma. The diagnosis of nesidioblastosis was based on exclusion of an insulinoma and conclusive pathological examination of a segment of the pancreas. Malignant insulinoma was defined as the presence of locoregional or distant metastases., Results: Based on histopathology, 13 patients were found to have pancreatic hyperinsulinaemia: two patients had malignant insulinoma, eight had nonmetastasized insulinoma, and three had nesidioblastosis. SR PET was positive in 11 of the 13 patients (84.6 %) with a final diagnosis of endogenous pancreatic hypoglycaemia. Histopathological staining confirmed 16 foci of hyperinsulinism (insulin positivity). SR PET detected 14 of the 16 lesions, resulting in a sensitivity of 87 %. One intrapancreatic spleen was falsely diagnosed as insulinoma focus on SR PET, resulting in positive predictive value of 93.3 %. Immunohistochemical staining of somatostatin receptor (SSR) subtype 2a was available in ten specimens: two nesidioblastosis, and seven benign and one malignant insulinoma. Eight out of the ten specimens (80 %) stained strongly to moderately positive. Seven of the eight SSR2a-positive lesions were picked up on SR PET. Based on the results of SR PET/CT, nine patients achieved complete remission of the hypoglycaemic events during follow-up., Conclusion: This explorative study suggests that SR PET in combination with CT may play a significant role in the detection and management of patients with pancreatogenic hyperinsulinaemic hypoglycaemia. A large proportion of insulinomas express SSR2a, and a larger study is needed to fully assess the diagnostic accuracy of SR PET in patients with insulinoma and nesidioblastosis compared with current localizing studies used in clinical practice.
- Published
- 2016
- Full Text
- View/download PDF
23. Multiple, Successful Pregnancies in Pompe Disease.
- Author
-
Plöckinger U, Tiling N, Bosanska L, Temmesfeld-Wollbrueck B, Irlbacher K, Mezger V, and Gossing G
- Abstract
Pompe disease is an autosomal recessive lysosomal storage disease characterized in adult patients by slowly progressive limb-girdle muscle weakness and respiratory insufficiency. Data on pregnancy in women with Pompe disease, intrauterine development of the fetus and parturition are rare. Here we describe a twin pregnancy followed by a second pregnancy in a 38-year-old female patient with Pompe disease. We report the impact of pregnancy on muscle and respiratory functions as well as the neurological and endocrine systems and discuss the medical consequences for anaesthetic management at parturition.
- Published
- 2016
- Full Text
- View/download PDF
24. Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.
- Author
-
Morris DA, Blaschke D, Krebs A, Canaan-Kühl S, Plöckinger U, Knobloch G, Walter TC, Kühnle Y, Boldt LH, Kraigher-Krainer E, Pieske B, and Haverkamp W
- Subjects
- Adult, Case-Control Studies, Echocardiography, Doppler, Female, Fibrosis, Glycogen Storage Disease Type II diagnosis, Heart Diseases etiology, Heart Diseases pathology, Heart Diseases physiopathology, Humans, Hypertrophy, Left Ventricular diagnosis, Hypertrophy, Left Ventricular etiology, Hypertrophy, Left Ventricular physiopathology, Hypertrophy, Right Ventricular diagnosis, Hypertrophy, Right Ventricular etiology, Hypertrophy, Right Ventricular physiopathology, Magnetic Resonance Imaging, Male, Middle Aged, Muscle, Skeletal pathology, Predictive Value of Tests, Risk Factors, Ventricular Dysfunction, Left diagnosis, Ventricular Dysfunction, Left etiology, Ventricular Dysfunction, Left physiopathology, Ventricular Dysfunction, Right diagnosis, Ventricular Dysfunction, Right etiology, Ventricular Dysfunction, Right physiopathology, Young Adult, Diagnostic Imaging methods, Glycogen Storage Disease Type II complications, Heart Diseases diagnosis, Myocardium pathology, Ventricular Function, Left, Ventricular Function, Right
- Abstract
The purpose of this study was to analyze comprehensively the heart using modern and sensitive myocardial techniques in order to determine if structural or functional cardiac alterations are present in adult Pompe disease. Twelve patients with adult Pompe disease and a control group of 187 healthy subjects of similar age and gender were included. Structural and functional cardiac characteristics were analyzed by conventional and 2D speckle-tracking echocardiography. In addition, in a subgroup of adult Pompe patients, we analyzed the myocardial and musculoskeletal features by means of cardiac and whole-body muscle magnetic resonance imaging. Patients with Pompe disease had significant structural and functional musculoskeletal alterations such as atrophy with fatty replacement and weakness in trunk and extremities. In contrast, Pompe patients had similar structural and functional myocardial features to healthy subjects (LV strain -20.7 ± 1.9 vs. -21.3 ± 2.1%; RV strain -24.2 ± 5.3 vs. -24.8 ± 3.8%; LA strain 41.5 ± 10.3 vs. 44.8 ± 11.0%; P > 0.05; and no evidence of LV and RV hypertrophy or LA enlargement). In addition, there was no evidence of valvular cardiac alterations, electrocardiographic abnormalities, or myocardial fibrosis in Pompe patients. In the current study analyzing the heart with modern and sensitive myocardial techniques, we evidenced that functional and structural cardiac alterations are not present when Pompe disease begins in adulthood. Therefore, these findings suggest that adult Pompe disease should not be taken into consideration in the differential diagnostic of structural or functional cardiac disorders.
- Published
- 2015
- Full Text
- View/download PDF
25. Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b.
- Author
-
Volz MS, Nassir M, Treese C, von Winterfeld M, Plöckinger U, Epple HJ, and Siegmund B
- Subjects
- Adult, Colon, Transverse surgery, Colonic Diseases surgery, Colonoscopy, Constriction, Pathologic etiology, Constriction, Pathologic surgery, Granulocyte-Macrophage Colony-Stimulating Factor administration & dosage, Humans, Leukocyte Count, Male, Pancytopenia etiology, Colon, Transverse pathology, Colonic Diseases etiology, Glycogen Storage Disease Type I complications, Inflammatory Bowel Diseases complications, Pancytopenia drug therapy
- Abstract
Background: Inflammatory bowel disease (IBD)-like conditions in glycogen storage disease (GSD) type Ib have been predominantly described in children. Signs and symptoms of GSD type Ib are hypoglycemia, pancytopenia and hepatosplenomegaly. Based on few published cases, there is evidence that granulocyte-colony stimulating factor (G-CSF) in patients with glycogenosis-related pancytopenia might ameliorate the IBD-like disease through leukocyte increase., Case Presentation: Here we firstly describe a case of an adult 33-year-old Caucasian male patient with GSD type Ib accompanied with IBD-like disease with persistent pancytopenia despite moderate-dose G-CSF treatment. Recent vomiting and abdominal discomfort were due to a high-grade stenosis in the transverse colon. A dose increase of the G-CSF successfully normalized his leukocyte count. However, the stenosis worsened and surgical therapy was needed., Conclusion: We suggest that symptomatic patients with GSD type Ib should undergo endoscopic examination in order to detect IBD-like disease and to initiate early treatment.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.